Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy. med./bio.

Published in: Cancer Immunol Immunother 2020; 69 (7): 1191-1204

Exposure